Clinical and genetic characterization of pheochromocytoma in von Hippel- Lindau families: Comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma

Journal of Urology

Volumn 162, Issue 3 I, 1999, Pages 659-664

  Walther, McClellan M ^a   Reiter, Robert ^a   Keiser, Harry R ^a   Choyke, Peter L ^a   Venzon, David ^a   Hurley, Kathy ^a   Gnarra, James R ^a   Reynolds, James C ^a   Glenn, Gladys M ^a   Zbar, Berton ^a   Linehan, W Marston ^a  

^a NONE

Author keywords

Diagnosis; Genetics; Hippel Lindau disease; Pheochromocytoma

Indexed keywords

ADRENALIN; CATECHOLAMINE; DOPAMINE; METADRENALIN; NORADRENALIN; VANILMANDELIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD PRESSURE; CANCER RISK; CATECHOLAMINE URINE LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; GENETIC SCREENING; GERM LINE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MISSENSE MUTATION; ONSET AGE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SCHOOL CHILD; VON HIPPEL LINDAU DISEASE;

EID: 6544234532     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-199909010-00004     Document Type: Article

References (32)

1. Maher, E. R., Yates, J. R., Harries, R., Benjamin, C., Harris, R., Moore, A. T. and Ferguson-Smith, M. A.: Clinical features and natural history of von Hippel-Lindau disease. Quart. J. Med., 77: 1151, 1990.
2. Glenn, G. M., Choyke, P., Zbar, B. and Linehan, W. M.: Von Hippel-Lindau Disease: Clinical review and molecular genetics. Prob. Urol., 4: 312, 1990.
3. Choyke, P. L., Glenn, G. M., Walther, M. M., Patronas, N. J., Linehan, W. M. and Zbar, B.: von Hippel-Lindau Disease: genetic, clinical, and imaging features. Radiology, 194: 629, 1995.
4. Chen, R., Kishida, T., Yao, M., Hustad, T., Glavac, D., Dean, M., Gnarra, J. R., Orcutt, M. L., Duh, F. M., Glenn, G., Green, J., Hsia, Y. E., Lamiell, J., Li, H., Wei, M. H., Schmidt, L., Tory, K., Kuzmin, I., Stackhouse, T., Latif, F., Linehan, W. M., Lerman, M. and Zbar, B.: Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum. Mut., 5: 66, 1995.
5. Crossey, P. A., Richards, F. M., Foster, K., Green, J. S., Prowse, A., Latif, F., Lerman, M. I., Zbar, B., Affara, N. A. and Ferguson-Smith, M. A.: Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum. Molec. Genet., 3: 1303, 1994.
6. Neumann, H. P., Berger, D. P., Sigmund, G., Blum, U., Schmidt, D., Parmer, R. J., Volk, B. and Kirste, G.: Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. New Engl. J. Med., 329: 1531, 1993.
7. Aprill, B. S., Drake, A. J., III, Lasseter, D. H. and Shakir, K. M.: Silent adrenal nodules in von Hippel-Lindau disease suggest pheochromocytoma. Ann. Intern. Med., 120: 485, 1994.
8. Atuk, N. O., McDonald, T., Wood, T., Carpenter, J. T., Walzak, M. P., Donaldson, M. and Gillenwater, J. Y.: Familial pheochromocytoma, hypercalcemia, and von Hippel-Lindau disease. A ten year study of a large family. Medicine (Baltimore), 58: 209, 1979.
9. Tisherman, S. E., Tisherman, B. G., Tisherman, S. A., Dunmire, S., Levey, G. S. and Mulvihill, J. J.: Three-decade investigation of familial pheochromocytoma. An allele of von Hippel-Lindau disease? Arch. Intern. Med., 153: 2550, 1993.
10. Grossman, E., Goldstein, D. S., Hoffman, A. and Keiser, H. R.: Glucagon and clonidine testing in the diagnosis of pheochromocytoma. Hypertension, 17: 733, 1991.
11. Keiser, H. R., Doppman, J. L., Robertson, C. N., Linehan, W. M. and Averbuch, S. D.: Diagnosis, localization, and management of pheochromocytoma. In: Pathology of the Adrenal Glands. Edited by E. E. Lack. New York: Churchill Livingstone, chapt. 13, pp. 237-255, 1990.
12. Koshida, H., Miyamori, I., Soma, R., Matsubara, T., Okamoto, S., Ikeda, M. and Takeda, R.: Evaluation of clonidine suppression and various provocation tests in the diagnosis of pheochromocytoma. J. Endocr. Invest., 13: 807, 1990.
13. Bravo, E. L.: Pheochromocytoma: new concepts and future trends. Kidney Int., 40: 544, 1991.
14. Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., Schmidt, L., Zhou, F., Ming, H. L., Wei, M. H., Chen, F., Glenn, G., Choyke, P., Walther, M. M., Weng, Y., Duan, D. S., Dean, M., Glavac, D., Richards, F. M., Crossey, P. A., Ferguson-Smith, M. A., Paslier, D., Chumakov, I., Cohen, D., Chinault, A. C., Maher, E., Linehan, W. M., Zbar, B. and Lerman, M. I.: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science, 260: 1317, 1993.
15. Bar, M., Friedman, E., Jakobovitz, O., Leibowitz, G., Lerer, I., Abeliovich, D. and Gross, D. J.: Sporadic phaeochromocytomas are rarely associated with germline mutations in the von Hippel-Lindau and RET genes. Clin. Endocr., 47: 707, 1997.
16. Woodward, E. R., Eng, C., McMahon, R., Voutilainen, R., Affara, N. A., Ponder, B. A. and Maher, E. R.: Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL. Hum. Molec. Genet., 6: 1051, 1997.
17. Neumann, H. P. H., Eng, C., Mulligan, L. M., Glavac, D., Zauner, I., Ponder, B. A. J., Crossey, P. A., Maher, E. R. and Brauch, H.: Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II. J.A.M.A., 274: 1149, 1995.
18. Walther, M. M. and Linehan, W. M.: Von Hippel-Lindau Disease and Pheochromocytoma (Letter to the Editor). J.A.M.A., 275: 839, 1996.
19. Eng, C., Clayton, D., Schuffenecker, I., Lenoir, G., Cote, G., Gagel, R. F., van Amstel, H. K., Lips, C. J., Nishisho, I., Takai, S. I., Marsh, D. J., Robinson, B. G., Frank-Raue, K., Raue, F., Xue, F., Noll, W. W., Romei, C., Pacini, F., Fink, M., Niederle, B., Zedenius, J., Nordenskjold, M., Komminoth, P., Hendy, G. N. and Mulligan, L. M.: The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. J.A.M.A., 276: 1575, 1996.
20. Raue, F.: German medullary thyroid carcinoma/multiple endocrine neoplasia registry. German MTC/MEN Study Group. Medullary thyroid carcinoma/multiple endocrine neoplasia type 2. Langenbecks. Arch. Surg., 383: 334, 1998.
21. Egawa, S., Futami, H., Takasaki, K., Iihara, M., Okamoto, T., Kanbe, M., Ohi, T., Saio, Y., Miyauchi, A., Takiyama, Y., Koga, M., Miyanaga, K., Inoue, K., Mitsuyama, S., Nomura, Y., Takei, H., Mugiya, S., Ishida, O., Zeze, F., Shakutsui, S., Inoue, H., Oya, H., Yoshimura, A., Ishizuka, S. and Yamaguchi, K.: Genotype-phenotype correlation of patients with multiple endocrine neoplasia type 2 in Japan. Jap. J. Clin. Oncol., 28: 590, 1998.
22. Richard, S., Beigelman, C., Duclos, J. M., Fendler, J. P., Plauchu, H., Plouin, P. F., Resche, F., Schlumberger, M., Vermesse, B. and Proye, C.: Pheochromocytoma as the first manifestation of von Hippel-Lindau disease. Surgery, 116: 1076, 1994.
23. Sato, T., Yoshinaga, K. and DeQuattro, V.: The relationship of the pattern of hypertension to biochemical findings in patients with pheochromocytoma. Jap. Heart J., 11: 423, 1970.
24. Crout, J. R. and Sjoerdsma, A.: Turnover and metabolism of catecholamine in patients with pheochromocytoma. J. Clin. Invest., 43: 94, 1964.
25. Levinson, P. D., Hamilton, B. P., Mersey, J. H. and Kowarski, A. A.: Plasma norepinephrine and epinephrine responses to glucagon in patients with suspected pheochromocytomas. Metabolism, 32: 998, 1983.
26. Siqueira-Filho, A. G., Sheps, S. G., Maher, F. T., Jiang, N. S. and Elveback, L. R.: Glucagon-blood catecholamine test: use in isolated and familial pheochromocytoma. Arch. Intern. Med., 135: 1227, 1975.
27. Lenders, J. W., Keiser, H. R., Goldstein, D. S., Willemsen, J. J., Friberg, P., Jacobs, M.-C., Kloppenborg, P. W., Thien, T. and Eisenhofer, G.: Plasma metanephrines in the diagnosis of pheochromocytoma. Ann. Intern. Med., 123: 101, 1995.
28. Norton, J. A. and Jensen, R. T.: Cancer of the endocrine system. In: Cancer: Principles and Practice of Oncology. Edited by V. T. DeVita, S. Hellman and S. A. Rosenberg. Philadelphia: Lippincott-Raven, chapt. 37.7, pp. 1723-1729, 1997.
29. Fernandez-Cruz, L., Saenz, A., Benarroch, G., Sabater, L. and Taura, P.: Total bilateral laparoscopic adrenalectomy in patients with Cushing's syndrome and multiple endocrine neoplasia (IIa). Surg. Endosc., 11: 103, 1997.
30. Pomares, F. J., Canas, R., Rodriguez, J. M., Hernandez, A. M., Parrilla, P. and Tebar, F. J.: Differences between sporadic and multiple endocrine neoplasia type 2A phaeochromocytoma. Clin. Endocr., 48: 195, 1998.
31. Okamoto, T., Obara, T., Ito, Y., Yamashita, T., Kanbe, M., Iihara, M., Hirose, K. and Yamazaki, K.: Bilateral adrenalectomy with autotransplantation of adrenocortical tissue or unilateral adrenalectomy: treatment options for pheochromocytomas in multiple endocrine neoplasia type 2A. Endocr. J., 43: 169, 1996.
32. Walther, M. M., Keiser, H. R., Choyke, P. L., Rayford, W., Lyne, J. C. and Linehan, W. M.: Management of hereditary pheochromocytoma in von Hippel-Lindau kindreds with partial adrenalectomy. J. Urol., 161: 395, 1999.